CSI Market
Sign In | Register

Ernexa Therapeutics Inc (ERNA) Annual Balance Sheets

Annual · GAAP · USD millions
Access ERNA quarterly Balance Sheets →
This page allows investors to track Ernexa Therapeutics Inc's balance sheet development across multiple reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent1.88
Cash, Cash Equivalents Other0.00
Cash & Short-term Investments1.00
Accounts receivable0.00
Other Receivables, Net, Current0.10
Other Current Assets0.75
Prepaid Expense And Other Assets Current0.40
Total Current Assets3.13
Equipment/Property/Plant Net0.09
Goodwill net2.04
Intangible Assets0.00
Long-term investments0.00
Other Assets, Noncurrent0.56
Restricted Cash Noncurrent-
Operating Lease Right Of Use Asset0.45
Total Assets5.83
Liabilities
Accounts Payable, Current AC1.13
Accrued Liabilities, Current AC0.90
Other Liabilities, Current1.05
Taxes Payable, Current, Total0.00
Deferred Revenue, Current DE0.00
Business Combination, Contingent Consideration, Liability, Current BU0.04
Total Current Liabilities3.11
Convertible Notes Payable, Noncurrent LO0.00
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE0.00
Deferred Revenue, Noncurrent DE0.00
Other liabilities, Noncurrent0.04
Operating Lease Liability Current0.21
Operating Lease Liability Noncurrent0.28
Total Liabilities3.43
Stockholders' Equity
Common Stock Value0.04
Additional Paid In Capital Common Stock248.00
Retained Earnings / Accumulated Deficit-245.64
Other Equity0.00
Common Stockholder's Equity2.40
Preferred Stockholder's Equity0.00
Total Stockholder's Equity2.40
Liabilities & Stockholder's Equity5.83
4 historic quarters locked

Sign in to unlock the full Ernexa Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Ernexa Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: March 13, 2026
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-010102

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License